Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies
Florian A. Lempp(VIR Biotechnology (United States)), Leah Soriaga(VIR Biotechnology (United States)), Martin Montiel-Ruiz(VIR Biotechnology (United States)), Fabio Benigni(Vir Biotechnology (Switzerland)), Julia Noack(VIR Biotechnology (United States)), Young‐Jun Park(University of Washington), Siro Bianchi(Vir Biotechnology (Switzerland)), Alexandra C. Walls(University of Washington), John E. Bowen(University of Washington), Jiayi Zhou(VIR Biotechnology (United States)), Hannah Kaiser(VIR Biotechnology (United States)), Anshu Joshi(University of Washington), Maria L. Agostini(VIR Biotechnology (United States)), Marcel Meury(VIR Biotechnology (United States)), Exequiel Dellota(VIR Biotechnology (United States)), Stefano Jaconi(Vir Biotechnology (Switzerland)), Elisabetta Cameroni(Vir Biotechnology (Switzerland)), Javier Martínez‐Picado(Universitat de Vic - Universitat Central de Catalunya), Júlia Vergara‐Alert(Centre de Recerca en Sanitat Animal), Nuria Izquierdo‐Useros(IrsiCaixa), Herbert W. Virgin(Washington University in St. Louis), Antonio Lanzavecchia(Vir Biotechnology (Switzerland)), David Veesler(University of Washington), Lisa A. Purcell, Amalio Telenti(VIR Biotechnology (United States)), Davide Corti(Vir Biotechnology (Switzerland))
Cited by 326
Abstract
Related Papers
No related papers found
Powered by citation graph analysis